Description

Find Therapeutics designs ground-breaking therapies through precision-targeting of membrane receptors to bring hope to people living with autoimmune diseases. The company was launched in 2020 with investments from CTI Life Sciences, adMare BioInnovations, and Domain Therapeutics, and GPCR technology and know-how from Peptimimesis Pharma.